Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Genetic tests which identify the principal defects in CYP2C19 responsible for the polymorphism in mephenytoin metabolism.

Methods in enzymology - 1 Jan 1996

Goldstein J A, Blaisdell J

Abstract excerpt

No abstract is available from the source.

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Anticonvulsants
Share to Aryl Hydrocarbon Hydroxylases
Share to Cytochrome P-450 CYP2C19
Share to Cytochrome P-450 Enzyme System

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Genetic Techniques

Share to Mephenytoin

Share to Mixed Function Oxygenases

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 8791779
DOI: 10.1016/s0076-6879(96)72025-6

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Genetic tests which identify the principal defects in CYP2C19 responsible for the polymorphism in mephenytoin metabolism.PMID 8791779Read ↗

CYP2C9 polymorphisms and phenytoin metabolism: implications for adverse effects.Semantic proximity Read ↗

Clinical Significance of the Cytochrome P450 2C19 Genetic PolymorphismSemantic proximity Read ↗

Detection of CYP2C19 alleles *1, *2 and *3 by multiplex polymerase chain reaction.Semantic proximity Read ↗

Genetic polymorphism of cytochrome P450 2C19 in healthy Malaysian subjects.Semantic proximity Read ↗

Frequencies of CYP2C9 polymorphisms in North Indian population and their association with drug levels in children on phenytoin monotherapy.Semantic proximity Read ↗

Phenytoin neurotoxicity in a child carrying new STXBP1 and CYP2C9 gene mutations.Semantic proximity Read ↗

Influence of the CYP2C9 AND CYP2C19 polymorphisms on phenytoin hydroxylation in healthy individuals from south India.Semantic proximity Read ↗

Pheno- or genotype for the CYP2C19 drug metabolism polymorphism: the influence of disease.Semantic proximity Read ↗

CYP2C9, CYP2C19, and ABCB1 genotype and hospitalization for phenytoin toxicity.Semantic proximity Read ↗

CYP2C9 polymorphisms in epilepsy: influence on phenytoin treatmentSemantic proximity Read ↗

Identification of new human CYP2C19 alleles (CYP2C19*6 and CYP2C19*2B) in a Caucasian poor metabolizer of mephenytoin.Semantic proximity Read ↗

Pharmacogenetic association between the formation of 4-hydroxymephenytoin and a new metabolite of S-mephenytoin in man.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.